Lotus Health Group Hits Day Low of CNY 10.02 Amid Price Pressure

Lotus Health Group Co. experienced a significant decline today, with the stock dropping by 7.31% to reach an intraday low of CNY 10.02. This performance stands in contrast to the China Shanghai Composite, which saw a modest decrease of 0.73% on the same day. Over the past week, Lotus Health Group has faced a more pronounced downturn, with a 13.62% decline compared to the composite index's 1.08% drop. In terms of longer-term performance, the stock has shown a year-to-date increase of 69.73%, significantly outperforming the China Shanghai Composite's 2.51% gain. However, over the past year, Lotus Health Group has underperformed the market, generating negative returns of 17.89% while the composite index achieved a 20.96% return. Key financial metrics reveal a return on equity of 14.42% and a price-to-book ratio of 5.81, indicating a relatively high valuation. The company’s inventory turnover ratio stands at 13.53 times, reflecting its operational efficiency. Despite recent challenges, Lotus Health Group remains a notable player in the FMCG sector with a market capitalization of CNY 18,449 million.